| 合并疾病 | 药物名称 | 频数(%) |
| 艾滋病(n = 1148) | 拉米夫定 | 756 (65.9%) |
| 替诺福韦 | 462 (40.2%) | |
| 洛匹那韦利托那韦 | 392 (34.1%) | |
| 依非韦伦 | 364 (31.7%) | |
| 齐多夫定 | 252 (22%) | |
| 艾考恩丙替 | 56 (4.9%) | |
| 艾博韦泰 | 28 (2.4%) | |
| 多替拉韦 | 28 (2.4%) | |
| 阿巴卡韦 | 28 (2.4%) | |
| 奈韦拉平 | 28 (2.4%) | |
| 高血压(n = 952) | 氨氯地平 | 238 (25%) |
| 厄贝沙坦 | 210 (22.1%) | |
| 美托洛尔 | 154 (16.2%) | |
| 硝苯地平 | 140 (14.7%) | |
| 培哚普利叔丁胺 | 112 (11.8%) | |
| 氢氯噻嗪 | 56 (5.9%) | |
| 拉西地平 | 42 (4.4%) | |
| 非洛地平 | 28 (2.9%) | |
| 尼群地平 | 14 (1.5%) | |
| 替米沙坦 | 14 (1.5%) | |
| 吲达帕胺 | 14 (1.5%) | |
| 普萘洛尔 | 14 (1.5%) | |
| 糖尿病(n = 420) | 门冬胰岛素 | 168 (40%) |
| 阿卡波糖 | 84 (20%) | |
| 甘精胰岛素 | 84 (20%) | |
| 恩格列净 | 28 (6.7%) | |
| 二甲双胍 | 28 (6.7%) | |
| 利格列汀 | 14 (3.3%) | |
| 地特胰岛素 | 14 (3.3%) | |
| 阿格列汀 | 14 (3.3%) | |
| 伏格列波糖 | 14 (3.3%) | |
| 血脂异常(n = 364) | 阿托伐他汀 | 84 (22.2%) |
| 瑞舒伐他汀 | 14 (3.7%) | |
| 非诺贝特 | 14 (3.7%) | |
| 慢性乙型病毒性肝炎(n = 168) | 替诺福韦 | 42 (25%) |
| 恩替卡韦 | 28 (16.7%) |